Lawrence Blonde
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 0.5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 102
- Diabetes Management and Research 65
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
- Diabetes Management and Education 9
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 8
-
- Metabolism, Diabetes, and Cancer 18
- Co-authors
- John B. Buse (7 shared papers)Julio Rosenstock (17 shared papers)Eduard Montanya (5 shared papers)Giorgio Sesti (3 shared papers)Wolfgang E. Schmidt (2 shared papers)Jason Brett (1 shared paper)Marcin Zychma (1 shared paper)Guillermo E. Umpierrez (10 shared papers)
- Journals
- Diabetes Obesity and Metabolism (26 papers)Endocrine Practice (24 papers)Diabetes Care (15 papers)Advances in Therapy (6 papers)Diabetes (6 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Lawrence Blonde
176 papers receiving 10.0k citations
Lawrence Blonde's Hit Papers
Peers
Comparison fields: 5 of 153
- Endocrinology, Diabetes and Metabolism 7.1k
- Pharmacology 1.1k
- Family Practice 107
- Surgery 1.9k
- Physiology 715
Countries citing papers authored by Lawrence Blonde
This map shows the geographic impact of Lawrence Blonde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Blonde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Blonde more than expected).
Fields of papers citing papers by Lawrence Blonde
This network shows the impact of papers produced by Lawrence Blonde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Blonde. The network helps show where Lawrence Blonde may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Blonde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) Hit paper breakdown → | 2009 | 1209 |
| 2 | Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) Hit paper breakdown → | 2009 | 712 |
| 3 | Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician Hit paper breakdown → | 2018 | 478 |
| 4 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary Hit paper breakdown → | 2020 | 422 |
| 5 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary Hit paper breakdown → | 2018 | 378 |
| 6 | 2006 | 355 | |
| 7 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary Hit paper breakdown → | 2017 | 331 |
| 8 | 2013 | 320 | |
| 9 | 2017 | 289 | |
| 10 | 2013 | 241 | |
| 11 | Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230)) | 2010 | 240 |
| 12 | 2019 | 227 | |
| 13 | American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update Hit paper breakdown → | 2023 | 225 |
| 14 | 2004 | 205 | |
| 15 | 2009 | 193 | |
| 16 | 2013 | 191 | |
| 17 | 2015 | 186 | |
| 18 | 2015 | 179 | |
| 19 | 2013 | 167 | |
| 20 | 2010 | 149 |
About Lawrence Blonde
Lawrence Blonde is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Pharmacology, Surgery and Epidemiology, having authored 183 papers that have together received 10.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (102 papers), Diabetes Management and Research (65 papers), Metabolism, Diabetes, and Cancer (18 papers), Pharmacology and Obesity Treatment (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Diabetes Management and Education (9 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers) and Diabetes and associated disorders (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.1k citations), Pharmacology (1.1k citations), Family Practice (107 citations), Surgery (1.9k citations) and Physiology (715 citations). Lawrence Blonde has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John B. Buse, Julio Rosenstock, Eduard Montanya, Giorgio Sesti, Wolfgang E. Schmidt, Jason Brett, Marcin Zychma, Guillermo E. Umpierrez, Paul S. Jellinger and Daniel Einhorn. Their work appears in journals such as Diabetes Obesity and Metabolism, Endocrine Practice, Diabetes Care, Advances in Therapy and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.